# OTICAIR
> **ANDA064065** · Abbreviated New Drug Application (Generic) · Sponsor: BAUSCH AND LOMB · Approved 1996-08-28
## Drug
- **FDA Application Number:** ANDA064065
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OTICAIR
- **Generic name:** NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE
- **Active ingredients:** HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
- **Dosage form:** SUSPENSION/DROPS
- **Route:** OTIC
- **Marketing status:** Prescription
- **Sponsor:** BAUSCH AND LOMB
- **Manufacturer:** Bausch & Lomb Incorporated
- **First approval:** 1996-08-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=064065)
---
*MORVS · CC0 1.0*